1st BPH study was fully enrolled on November 28th 2012, so yes you are right for end of November early December. In regards to a completion date for the cancer trial, Dr. A mentioned specifically that Nymox never provides a completion timeline because so many factors are out of their control, but he said end of year 2013 beginning 2014 as a loose timeframe. The study began enrolling in June 2012 abd reached halfway point In April 2013, so if it continues on the same pace, we are looking towards December 2013 or January 2014 for full enrollment.
Sentiment: Strong Buy
Appreciate the review. Any speculation as to completion date for prostate carcinoma study?
Another thing I find puzzling is everyone talks about November as results for the first phase three. From what I remember the last patient was dosed end of Nov. last year so study results at the earliest would be late Dec/early January. Can someone correct me if I am wrong.
I hope for your sake that it works out..I prefer ACAD which has support of Baker Brothers......NYMOX may have the Greatest BPH drug ever, however, the Biotech Hedge funds generally can find information through channel checks or questioning urologists and then have enough to invest....When all of us thought this was a good investment we relied on generalities from Dr A....That SHOULD not be enough for an investment only a gamble...If that is how you view it then you will be fine....I had more than 125K in this stock and after 8 years someone in the know should have found something worth investing.....Dr A is far too arrogant to run this company...IMO
Few people in attendance...general sentiment is that we are on the final stretch of the process and it seems that Dr. A has been under a lot of pressure to deliver, but as he states, he is not going to "roll over" and hand over a partnership for US or Asia without maximizing shareholder value. If successful, the results of the 1st phase III study coming November 2013 will put Nymox in a position of strength in negotiations.
Dr. A was very enthusiastic about the prospects of the cancer study. He mentioned that it was a huge vote of confidence for the trial to be vaulted into late stage II testing right away by a seperate panel review board then that of the BPH trial something that only happens if the safety profile is pristine.
My view is that things will be quiet from here on in until November, so we can all expect to hear from WRB saying that Nymox will never accomplish anything until then, but i am staying long and strong
Sentiment: Strong Buy
Mr.Bob can you ask Mr. A.P.a estimated Study Completion Date of the trial of
Two-Dose NX-1207 for the Treatment of Low Risk prostate cancer
it should have been completed.
It appears to be a protein with amino acids difines as neural tube protein. It appears to induce local cell death with no inflammation. yMy guess. Anticipating approvel in late spring early summer 2014 optimistically. Awaiting partnering and of course final results
All speculation on my part
Do you suffer from BPH? I do and I have found that removing caffeine and reducing intake after 9pm works wonders...Fact is I have been living with it for 10 years and I guarantee you that any man that gets prescribed Cialis will not only appreciate the improvement in BPH but also enjoy feeling like they are 21 again...I doubt if NX-1207 will ever do that....Men are buying Cialis like its going out of style and paying out of pocket for it....When you are prescribed it for BPH, the insurance covers and it works wonders.....
I don't recall them ever presenting at a major firm's health conference before... interesting.... doesn't mean that Jefferies is endorsing it, but interesting nonetheless......
won't necessarily be the preferred treatment for most men??? a meaningless statement... the current methods of shrinking the prostate are FAR more invasive and risk unwanted side effects, and this shot will be vastly preferred relative to the other invasions.... some may prefer cialis, flomax or the others, but a one time shot that provides a few minutes of discomfort in exchange for a few years of relief seems very attractive....
If the large hedge and investment funds are so smart why are index funds etc growing in popularity? What percentage of the above "Pro's" actually beat an S&P index fund each year (I'll give you a hint - not many).
If NX 1207 is monkey snot does it matter if it works and they have it patented? What benefit does Nymox gain from telling the world about the chemical specifics of NX 1207? Impress the competition?
You seem to have the most trouble sticking to the facts. Phase 3 is fully enrolled and all the results to date have been superior to what's currently available in the marketplace.
You need to come up with some new (and better) material. Editorials don't count for much unless it lowers your blood pressure. If that's the case please continue.
Paul doesn't care to hear from me anymore....I think that REGARDLESS of the success of the drug, Even when I spoke with Neal Shore, he said even if the the drug works, it won't necessarily be the preferred treatment for most men...Needles are rarely the preferred treatment
Not making jokes, i am at least willing to acknowledge that the stock can end up being a complete disaster, you are the one that is not willing to acknowledge the possibility of it's success. Many prominent urologists have given their vote of confidence that if approved, nx-1207 could change the landscape of how to treat BPH...unless of course Paul is greasing them with his enourmous 120k annual salary.
I'll make you a deal, i'll give you 5 dollars so you can buy 1 share of NYMX, and i want you to come to the shareholders meeting next week and address your issues to Paul directly, that would be a treat ( i know its too late, but it would be fun)